The below blog post has been written by the research team, and details of how to participate in the research can be found at the bottom of this post. Verity have sighted the ethics approval granted for the recruitment of this study.
Glucagon-like peptide-1 (GLP-1) receptor agonists—such as semaglutide and tirzepatide—are medications that can help with weight management. However, little is known about people’s experiences using GLP-1s for weight loss, especially among those with PCOS.
We are looking to interview people with PCOS who have used GLP-1 medications to learn about their experiences and perspectives.
This research is part of a PhD project at the University of Oxford and has been approved by the University of Oxford Medical Sciences Interdivisional Research Ethics Committee.
What’s Involved?
A one-hour interview via phone call or Microsoft Teams to discuss your experiences with GLP-1 use and PCOS.
Who Can Take Part?
You can take part if you:
- Are aged 18+
- Live in England
- Have a formal PCOS diagnosis
- Are currently or have previously taken a GLP-1 medication through a public or private prescription
- Have a current or previous BMI of:
- 30+ kg/m², or
- 27.5+ kg/m² if you are from Asian, Middle Eastern, Black, African, or African-Caribbean backgrounds
You cannot take part if you:
- Received/are receiving the GLP-1 through a clinical trial
- Received/are receiving GLP-1 prescriptions exclusively from outside the UK
Why Take Part?
You will receive a £25 shopping voucher as a thank you for your time and help contribute to the knowledge base on how people with PCOS experience GLP-1 use.
How to Get Involved
If you’re interested, please contact Sabrina Keating:
- Email: Sabrina.keating@phc.ox.ac.uk
- Phone: 01865 289295
About the Researcher(s)
Sabrina Keating is a PhD student with a background in women’s health research and lived experience of PCOS.
Thank you for your interest! Please feel free to share this research opportunity with others who may be eligible.
Verity - The PCOS charity 